← Back to Screener
Revolution Medicines, Inc. Warrant (RVMDW)
Price$6.26
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)806.60%
Price vs S&P 500 (4W)4.96%
VGM Score94.95
All Metrics
Price vs S&P 500 (YTD)514.21%
10-Day Avg Trading Volume0.10M
3-Month Avg Trading Volume0.13M
52-Week Price Return4626.69%
52-Week High$7.29
26-Week Price Return820.19%
13-Week Price Return186.83%
3-Month Return Std Dev285.36%
Price vs S&P 500 (52W)4598.54%
Year-to-Date Return525.60%
5-Day Price Return1.20%
Month-to-Date Return-5.62%
Price vs S&P 500 (13W)176.17%
Beta5.17x
52-Week Low$0.10
mGradeA
vgmGradeA
Show chart for
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
RVMDWRevolution Medicines, Inc. Warrant | — | — | A | $6.26 |
| AMGNAmgen Inc | C | C | C | $338.22 |
| GILDGilead Sciences Inc | C | B | C | $128.99 |
| ARGXargenx SE American Depositary Shares | D | A | B | $813.14 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $155.99 |
| BIIBBiogen Inc. Common Stock | B | D | C | $195.96 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.45 |
| MRNAModerna, Inc. Common Stock | C | B | C | $49.06 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $165.11 |
| EXELExelixis Inc | C | B | B | $51.60 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | B | $301.82 |
About
Revolution Medicines is a clinical-stage precision oncology company developing targeted therapies for RAS-addicted cancers, a significant unmet need in oncology. Using proprietary structure-based drug discovery, the company creates small molecules that target unconventional binding sites on RAS variants. Its pipeline features RAS(ON) Inhibitors designed as monotherapy or combination treatments.